JP2019503980A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019503980A5 JP2019503980A5 JP2017562979A JP2017562979A JP2019503980A5 JP 2019503980 A5 JP2019503980 A5 JP 2019503980A5 JP 2017562979 A JP2017562979 A JP 2017562979A JP 2017562979 A JP2017562979 A JP 2017562979A JP 2019503980 A5 JP2019503980 A5 JP 2019503980A5
- Authority
- JP
- Japan
- Prior art keywords
- ligand
- complex
- linker
- alkyl
- conjugate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562260046P | 2015-11-25 | 2015-11-25 | |
| US62/260,046 | 2015-11-25 | ||
| PCT/IB2016/001772 WO2017089890A1 (en) | 2015-11-25 | 2016-11-23 | Conjugates comprising self-immolative groups and methods related thereto |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019503980A JP2019503980A (ja) | 2019-02-14 |
| JP2019503980A5 true JP2019503980A5 (https=) | 2020-01-09 |
| JP6949732B2 JP6949732B2 (ja) | 2021-10-13 |
Family
ID=58763083
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017562979A Active JP6949732B2 (ja) | 2015-11-25 | 2016-11-23 | 自壊性基を含む複合体及びそれに関連した方法 |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US11413353B2 (https=) |
| EP (1) | EP3380124B1 (https=) |
| JP (1) | JP6949732B2 (https=) |
| KR (1) | KR102847342B1 (https=) |
| CN (4) | CN118105513A (https=) |
| AU (1) | AU2016359230B2 (https=) |
| CA (1) | CA3006242A1 (https=) |
| DK (1) | DK3380124T3 (https=) |
| ES (1) | ES2979090T3 (https=) |
| FI (1) | FI3380124T3 (https=) |
| HR (1) | HRP20240795T1 (https=) |
| HU (1) | HUE067016T2 (https=) |
| LT (1) | LT3380124T (https=) |
| PL (1) | PL3380124T3 (https=) |
| PT (1) | PT3380124T (https=) |
| RS (1) | RS65660B1 (https=) |
| SI (1) | SI3380124T1 (https=) |
| SM (1) | SMT202400223T1 (https=) |
| TW (1) | TWI801332B (https=) |
| WO (1) | WO2017089890A1 (https=) |
Families Citing this family (58)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3019559A4 (en) | 2013-08-22 | 2017-04-05 | Sony Corporation | Water soluble fluorescent or colored dyes and methods for their use |
| KR101628872B1 (ko) * | 2014-05-28 | 2016-06-09 | 주식회사 레고켐 바이오사이언스 | 자가-희생 기를 포함하는 화합물 |
| US11827661B2 (en) | 2015-02-26 | 2023-11-28 | Sony Group Corporation | Water soluble fluorescent or colored dyes comprising conjugating groups |
| WO2017051249A1 (en) | 2015-09-25 | 2017-03-30 | Legochem Biosciences, Inc. | Compositions and methods related to anti-cd19 antibody drug conjugates |
| WO2017051254A1 (en) * | 2015-09-25 | 2017-03-30 | Legochem Biosciences, Inc. | Compositions and methods related to anti-egfr antibody drug conjugates |
| AU2016359230B2 (en) | 2015-11-25 | 2020-04-23 | Ligachem Biosciences Inc. | Conjugates comprising self-immolative groups and methods related thereto |
| AU2016359235B2 (en) | 2015-11-25 | 2022-09-15 | Ligachem Biosciences Inc. | Antibody-drug conjugates comprising branched linkers and methods related thereto |
| KR102847348B1 (ko) | 2015-11-25 | 2025-08-19 | 주식회사 리가켐바이오사이언스 | 펩타이드 그룹을 포함하는 접합체 및 이와 관련된 제조방법 |
| AU2017240154B2 (en) | 2016-04-01 | 2021-08-12 | Sony Group Corporation | Ultra bright dimeric or polymeric dyes |
| WO2017177065A2 (en) | 2016-04-06 | 2017-10-12 | Sony Corporation | Ultra bright dimeric or polymeric dyes with spacing linker groups |
| EP3455300A1 (en) | 2016-05-11 | 2019-03-20 | Sony Corporation | Ultra bright dimeric or polymeric dyes |
| JP7312929B2 (ja) | 2016-07-29 | 2023-07-24 | ソニーグループ株式会社 | 超明色二量体またはポリマー色素およびその調製のための方法 |
| KR102480965B1 (ko) | 2016-09-13 | 2022-12-26 | 알레간 인코포레이티드 | 안정화된 비단백질 클로스트리듐 독소 조성물 |
| CA3058360A1 (en) | 2017-03-29 | 2018-10-04 | Legochem Biosciences, Inc. | Pyrrolobenzodiazepine dimer prodrug and ligand-linker conjugate compound of the same |
| WO2018218004A1 (en) | 2017-05-24 | 2018-11-29 | The Board Of Regents Of The University Of Texas System | Linkers for antibody drug conjugates |
| KR20260011205A (ko) | 2017-10-05 | 2026-01-22 | 소니그룹주식회사 | 프로그램가능한 중합체성 약물 |
| WO2019071153A1 (en) | 2017-10-05 | 2019-04-11 | Sony Corporation | PROGRAMMABLE DENDRITIC MEDICINES |
| CN111836645A (zh) | 2017-11-16 | 2020-10-27 | 索尼公司 | 可编程的聚合药物 |
| US12539334B2 (en) | 2018-01-12 | 2026-02-03 | Sony Group Corporation | Phosphoalkyl polymers comprising biologically active agents |
| EP3737417B1 (en) | 2018-01-12 | 2025-08-27 | Sony Group Corporation | Phosphoalkyl ribose polymers comprising biologically active compounds |
| CN111565756A (zh) | 2018-01-12 | 2020-08-21 | 索尼公司 | 包含生物活性化合物的具有刚性间隔基团的聚合物 |
| KR102742386B1 (ko) | 2018-03-19 | 2024-12-16 | 소니그룹주식회사 | 형광 신호 향상을 위한 2가 금속의 사용 |
| CN118480073A (zh) | 2018-03-21 | 2024-08-13 | 索尼公司 | 具有连接体基团的聚合串联染料 |
| WO2019183270A1 (en) * | 2018-03-23 | 2019-09-26 | The Regents Of The University Of California | Puromycin-based probes and methods of use thereof |
| CN112601555A (zh) * | 2018-05-09 | 2021-04-02 | 乐高化学生物科学股份有限公司 | 与抗cd19抗体药物结合物相关的组合物和方法 |
| JP7580689B2 (ja) | 2018-06-27 | 2024-11-12 | ソニーグループ株式会社 | デオキシリボースを含むリンカー基を有するポリマー色素 |
| KR20210032434A (ko) | 2018-07-13 | 2021-03-24 | 소니 주식회사 | 유기인산염 단위를 포함하는 백본을 갖는 중합체성 염료 |
| WO2020141923A2 (ko) * | 2019-01-03 | 2020-07-09 | 주식회사 레고켐 바이오사이언스 | 안전성이 향상된 피롤로벤조디아제핀 이량체 화합물 및 이의 용도 |
| KR20200084802A (ko) * | 2019-01-03 | 2020-07-13 | 주식회사 레고켐 바이오사이언스 | 안전성이 향상된 피롤로벤조디아제핀 이량체 화합물 및 이의 용도 |
| KR102501394B1 (ko) * | 2019-05-02 | 2023-02-21 | 주식회사 레고켐 바이오사이언스 | 트리스 구조를 가지는 링커를 포함하는 리간드-약물 접합체 |
| JP2022530482A (ja) * | 2019-05-02 | 2022-06-29 | レゴケム バイオサイエンシズ， インク． | トリス構造を有するリンカーを含むリガンド―薬物複合体 |
| KR20210028544A (ko) | 2019-09-04 | 2021-03-12 | 주식회사 레고켐 바이오사이언스 | 인간 ror1에 대한 항체를 포함하는 항체 약물 접합체 및 이의 용도 |
| WO2021062176A2 (en) | 2019-09-26 | 2021-04-01 | Sony Corporation | Polymeric tandem dyes with linker groups |
| EP4038081A1 (en) | 2019-09-30 | 2022-08-10 | Sony Group Corporation | Nucleotide probes |
| AR120218A1 (es) * | 2019-10-15 | 2022-02-02 | Heidelberg Pharma Res Gmbh | Conjugados de amatoxina y anticuerpo específico de linfocitos b |
| KR102326738B1 (ko) * | 2019-12-12 | 2021-11-15 | 고려대학교 산학협력단 | 다중약물내성 극복을 위한 항암 약물전구체 |
| KR20210086557A (ko) * | 2019-12-31 | 2021-07-08 | 주식회사 레고켐 바이오사이언스 | 피롤로벤조디아제핀 유도체 및 이의 리간드-링커 접합체 |
| EP4093439A1 (en) * | 2020-01-22 | 2022-11-30 | MedImmune Limited | Compounds and conjugates thereof |
| IL298999A (en) | 2020-06-11 | 2023-02-01 | Provention Bio Inc | Methods and compositions for the prevention of type 1 diabetes |
| EP4256078A1 (en) | 2020-12-07 | 2023-10-11 | Sony Group Corporation | Spacing linker group design for brightness enhancement in dimeric or polymeric dyes |
| CN112679448B (zh) * | 2020-12-31 | 2022-08-19 | 苏州昊帆生物股份有限公司 | N-(2-氨基乙基)吗啉的制备方法 |
| AU2022230398A1 (en) * | 2021-03-03 | 2023-08-31 | R.P. Scherer Technologies, Llc | Branched linkers for antibody-drug conjugates and methods of use thereof |
| EP4301782A1 (en) | 2021-03-05 | 2024-01-10 | Go Therapeutics, Inc. | Anti-glyco-cd44 antibodies and their uses |
| WO2022211508A1 (ko) | 2021-03-30 | 2022-10-06 | 주식회사 레고켐바이오사이언스 | 인간 cldn18.2에 대한 항체를 포함하는 항체 약물 접합체 및 이의 용도 |
| JP2024520444A (ja) | 2021-05-24 | 2024-05-24 | プロヴェンション・バイオ・インコーポレイテッド | １型糖尿病を治療するための方法 |
| US20250101126A1 (en) | 2021-08-05 | 2025-03-27 | Go Therapeutics, Inc. | Anti-glyco-muc4 antibodies and their uses |
| CN113636931B (zh) * | 2021-08-05 | 2024-02-13 | 康龙化成(宁波)科技发展有限公司 | 基因编码化合物库起始头片段化合物及其在基因编码化合物库合成上的应用 |
| CN113979889A (zh) * | 2021-11-09 | 2022-01-28 | 西安康福诺生物科技有限公司 | 一种双官能化聚乙二醇基胺的合成方法 |
| GB202203070D0 (en) | 2022-03-04 | 2022-04-20 | Iksuda Therapeutics Ltd | Anti-canag antibody conjugate |
| GB202210407D0 (en) | 2022-07-15 | 2022-08-31 | Iksuda Therapeutics Ltd | Folate receptor targeting antibody-drug conjugates |
| KR20240077919A (ko) * | 2022-11-25 | 2024-06-03 | 주식회사 레고켐 바이오사이언스 | 링커-약물 접합체 제조방법 |
| WO2024173384A1 (en) | 2023-02-14 | 2024-08-22 | Bolt Biotherapeutics, Inc. | Aza-benzazepine immunoconjugates, and uses thereof |
| GB202313214D0 (en) | 2023-08-30 | 2023-10-11 | Iksuda Therapeutics Ltd | Co-administration of antibody-drug conjugate |
| CN119818702A (zh) * | 2024-01-16 | 2025-04-15 | 复星医药产业发展(深圳)有限公司 | 一种含抗体药物偶联物的药物组合物及其应用 |
| CN118754934B (zh) * | 2024-06-05 | 2025-02-07 | 浙江新码生物医药有限公司 | 一种用于制备药物偶联物的毒素衍生物 |
| CN118846111B (zh) * | 2024-06-27 | 2025-12-26 | 浙江新码生物医药有限公司 | 一种抗trop2抗体-药物偶联物及其制备方法和用途 |
| WO2026050214A1 (en) | 2024-08-27 | 2026-03-05 | Bolt Biotherapeutics, Inc. | Anti-claudin, tlr agonist immunoconjugates and uses thereof |
| WO2026085104A1 (en) * | 2024-10-15 | 2026-04-23 | Solve Therapeutics, Inc. | Drug conjugates and uses thereof |
Family Cites Families (71)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| US5112739A (en) * | 1988-08-02 | 1992-05-12 | Polaroid Corporation | Enzyme controlled release system |
| GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
| US5175384A (en) | 1988-12-05 | 1992-12-29 | Genpharm International | Transgenic mice depleted in mature t-cells and methods for making transgenic mice |
| ATE158021T1 (de) | 1990-08-29 | 1997-09-15 | Genpharm Int | Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper |
| US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
| US5635483A (en) | 1992-12-03 | 1997-06-03 | Arizona Board Of Regents Acting On Behalf Of Arizona State University | Tumor inhibiting tetrapeptide bearing modified phenethyl amides |
| CA2115811A1 (en) | 1993-02-17 | 1994-08-18 | Claus Krebber | A method for in vivo selection of ligand-binding proteins |
| DE19512484A1 (de) | 1995-04-04 | 1996-10-17 | Bayer Ag | Kohlenhydratmodifizierte Cytostatika |
| DE19544393A1 (de) | 1995-11-15 | 1997-05-22 | Hoechst Schering Agrevo Gmbh | Synergistische herbizide Mischungen |
| EP0795334B1 (de) | 1996-03-12 | 2006-02-01 | Sanofi-Aventis Deutschland GmbH | Neuartige Prodrugs für die Therapie von Tumoren und entzündlichen Erkrankungen |
| US6218519B1 (en) | 1996-04-12 | 2001-04-17 | Pro-Neuron, Inc. | Compounds and methods for the selective treatment of cancer and bacterial infections |
| US6759509B1 (en) | 1996-11-05 | 2004-07-06 | Bristol-Myers Squibb Company | Branched peptide linkers |
| JP2001505194A (ja) | 1996-11-05 | 2001-04-17 | ブリストル―マイヤーズ・スクイブ・カンパニー | 分枝ペプチド・リンカー |
| EP1391213A1 (en) | 2002-08-21 | 2004-02-25 | Boehringer Ingelheim International GmbH | Compositions and methods for treating cancer using maytansinoid CD44 antibody immunoconjugates and chemotherapeutic agents |
| DE60303825T2 (de) | 2002-08-22 | 2006-08-17 | Neurosearch A/S | Verfahren zum herstellen von enantiomeren von indol-2,3-dion-3-oxim-derivaten |
| JP2006510626A (ja) | 2002-12-05 | 2006-03-30 | シエーリング アクチエンゲゼルシャフト | 増殖疾患の処理における部位特異的供給のためのエポチロン類似体 |
| EP2478912B1 (en) | 2003-11-06 | 2016-08-31 | Seattle Genetics, Inc. | Auristatin conjugates with anti-HER2 or anti-CD22 antibodies and their use in therapy |
| AR048098A1 (es) | 2004-03-15 | 2006-03-29 | Wyeth Corp | Conjugados de caliqueamicina |
| SV2007002227A (es) | 2004-09-10 | 2007-03-20 | Wyeth Corp | Anticuerpos anti-5t4 humanizados y conjugados anticuerpo anti-5t4/calicheamicina ref. 040000-0317637 |
| DK3248613T3 (da) | 2005-07-18 | 2022-03-14 | Seagen Inc | Beta-glucuronid-lægemiddel-linkerkonjugater |
| CN101287500A (zh) | 2005-08-19 | 2008-10-15 | 恩多塞特公司 | 多药物配体缀合物 |
| BRPI0716808A2 (pt) | 2006-09-15 | 2013-11-05 | Enzon Pharmaceuticals Inc | Ligantes poliméricos baseados em lisina |
| KR101512203B1 (ko) | 2006-11-10 | 2015-04-15 | 가부시키가이샤 리부텍쿠 | ｉｎ ｖｉｖｏ 에서 항종양 활성을 갖는 항인간 Ｄｌｋ－１ 항체 |
| CL2007003622A1 (es) | 2006-12-13 | 2009-08-07 | Medarex Inc | Anticuerpo monoclonal humano anti-cd19; composicion que lo comprende; y metodo de inhibicion del crecimiento de celulas tumorales. |
| JP5404624B2 (ja) | 2007-08-01 | 2014-02-05 | カウンスィル オブ サイエンティフィック アンド インダストリアル リサーチ | 選択的な抗腫瘍薬として有用なピロロ［２，１−ｃ］［１，４］ベンゾジアゼピン−グリコシドプロドラッグ |
| CA2759733C (en) | 2009-04-23 | 2019-09-03 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Anti-human ror1 antibodies |
| WO2011066418A1 (en) | 2009-11-25 | 2011-06-03 | Academia Sinica | The tumor-selective anti-cancer prodrug bqc-g |
| CA2795349C (en) * | 2010-04-15 | 2016-11-29 | Seattle Genetics, Inc. | Targeted pyrrolobenzodiazepine conjugates |
| FR2960153B1 (fr) | 2010-05-20 | 2012-08-17 | Centre Nat Rech Scient | Nouveaux bras autoreactifs et prodrogues les comprenant |
| US9591882B2 (en) | 2010-08-05 | 2017-03-14 | Robert LaGrand Duffin | Absorbent sleeve |
| EP3828205A1 (en) | 2010-10-01 | 2021-06-02 | Oxford BioTherapeutics Ltd | Anti-ror1 antibodies |
| KR20120107741A (ko) | 2011-03-22 | 2012-10-04 | 한국생명공학연구원 | 패혈증 단백질 치료제의 효능 분석 및 스크리닝 방법 |
| KR101461706B1 (ko) | 2011-04-04 | 2014-11-18 | 한국생명공학연구원 | Ｄｌｋ１ 세포 외 수용성 도메인을 포함하는 액티빈 수용체 타입 2ｂ 억제제 |
| CN103502990A (zh) | 2011-04-29 | 2014-01-08 | 惠普发展公司，有限责任合伙企业 | 用于事件的内存中处理的系统和方法 |
| MX393973B (es) | 2011-05-08 | 2025-03-24 | Legochem Biosciences Inc | Conjugados de proteína-agente activo y método para su preparación. |
| CA2850373C (en) | 2011-10-14 | 2019-07-16 | Seattle Genetics, Inc. | Pyrrolobenzodiazepines and targeted conjugates |
| BR112014009050B1 (pt) | 2011-10-14 | 2022-06-21 | Medimmune Limited | Conjugado anticorpo-fármaco de pirrolbenzodiazepinas, composição farmacêutica que compreende o mesmo, bem como compostos de pirrolbenzodiazepinas |
| EP2800586A1 (en) | 2012-01-03 | 2014-11-12 | Invictus Oncology Pvt. Ltd. | Ligand-targeted molecules and methods thereof |
| CN105189507A (zh) | 2012-12-21 | 2015-12-23 | 斯皮罗根有限公司 | 吡咯并苯并二氮杂卓及其结合物 |
| MX2015012549A (es) | 2013-03-15 | 2016-06-21 | Abbvie Deutschland | Formulaciones de conjugado anticuerpo anti-egfr-farmaco. |
| WO2014194030A2 (en) | 2013-05-31 | 2014-12-04 | Immunogen, Inc. | Conjugates comprising cell-binding agents and cytotoxic agents |
| US20160256561A1 (en) | 2013-10-11 | 2016-09-08 | Medimmune Limited | Pyrrolobenzodiazepine-antibody conjugates |
| NZ758049A (en) | 2013-10-15 | 2024-03-22 | Seagen Inc | Pegylated drug-linkers for improved ligand-drug conjugate pharmacokinetics |
| EA201691075A1 (ru) | 2013-11-26 | 2016-09-30 | Новартис Аг | Способы оксимной конъюгации с кетон-модифицированными полипептидами |
| KR102442906B1 (ko) | 2013-12-19 | 2022-09-14 | 씨젠 인크. | 표적화된-약물 컨쥬게이트와 함께 사용되는 메틸렌 카바메이트 링커 |
| EP2913064A1 (en) | 2014-02-26 | 2015-09-02 | celares GmbH | Branched drug-linker conjugates for the coupling to biological targeting molecules |
| KR101628872B1 (ko) | 2014-05-28 | 2016-06-09 | 주식회사 레고켐 바이오사이언스 | 자가-희생 기를 포함하는 화합물 |
| TWI751102B (zh) | 2014-08-28 | 2022-01-01 | 美商奇諾治療有限公司 | 對ｃｄ１９具專一性之抗體及嵌合抗原受體 |
| FI3900742T3 (fi) | 2014-09-11 | 2024-08-16 | Seagen Inc | Tertiääristä amiinia sisältävien lääkeaineiden kohdennettu antaminen |
| CN107207553A (zh) | 2014-12-09 | 2017-09-26 | 艾伯维公司 | Bcl‑xl抑制性化合物和包括其的抗体药物缀合物 |
| KR20160080832A (ko) | 2014-12-29 | 2016-07-08 | 주식회사 레고켐 바이오사이언스 | 리피바디 유도체-약물 복합체, 그 제조방법 및 용도 |
| ES2818103T3 (es) | 2015-01-16 | 2021-04-09 | Juno Therapeutics Inc | Anticuerpos y receptores de antígenos quiméricos específicos para ROR1 |
| PT3250237T (pt) | 2015-01-30 | 2021-06-30 | Sutro Biopharma Inc | Derivados de hemiasterlina para conjugação e terapêutica |
| WO2017051254A1 (en) | 2015-09-25 | 2017-03-30 | Legochem Biosciences, Inc. | Compositions and methods related to anti-egfr antibody drug conjugates |
| WO2017051249A1 (en) | 2015-09-25 | 2017-03-30 | Legochem Biosciences, Inc. | Compositions and methods related to anti-cd19 antibody drug conjugates |
| MY196631A (en) | 2015-10-13 | 2023-04-24 | Eureka Therapeutics Inc | Antibody Agents Specific for Human Cd19 and uses Thereof |
| KR102847348B1 (ko) | 2015-11-25 | 2025-08-19 | 주식회사 리가켐바이오사이언스 | 펩타이드 그룹을 포함하는 접합체 및 이와 관련된 제조방법 |
| AU2016359230B2 (en) | 2015-11-25 | 2020-04-23 | Ligachem Biosciences Inc. | Conjugates comprising self-immolative groups and methods related thereto |
| AU2016359235B2 (en) | 2015-11-25 | 2022-09-15 | Ligachem Biosciences Inc. | Antibody-drug conjugates comprising branched linkers and methods related thereto |
| GB201617466D0 (en) | 2016-10-14 | 2016-11-30 | Medimmune Ltd | Pyrrolobenzodiazepine conjugates |
| WO2018083535A1 (en) | 2016-11-04 | 2018-05-11 | Novimmune Sa | Anti-cd19 antibodies and methods of use thereof |
| CA3058360A1 (en) | 2017-03-29 | 2018-10-04 | Legochem Biosciences, Inc. | Pyrrolobenzodiazepine dimer prodrug and ligand-linker conjugate compound of the same |
| AU2018289581C1 (en) | 2017-06-23 | 2025-01-30 | VelosBio Inc. | ROR1 antibody immunoconjugates |
| KR20190018400A (ko) | 2017-08-14 | 2019-02-22 | 주식회사 레고켐 바이오사이언스 | EGFRvIII에 대한 항체를 포함하는 항체 약물 접합체 |
| CN111278860B (zh) | 2017-09-08 | 2024-03-29 | Y生物股份有限公司 | 抗人dlk1的抗体及其用途 |
| CN112601555A (zh) | 2018-05-09 | 2021-04-02 | 乐高化学生物科学股份有限公司 | 与抗cd19抗体药物结合物相关的组合物和方法 |
| WO2019225777A1 (ko) | 2018-05-23 | 2019-11-28 | 에이비엘바이오 주식회사 | 항-ror1 항체 및 그 용도 |
| EP3936150A4 (en) | 2019-03-06 | 2023-03-29 | LegoChem Biosciences, Inc. | ANTIBODY-DRUG CONJUGATES COMPRISING ANTIBODY AGAINST HUMAN DLK1 AND USE THEREOF |
| KR20210028544A (ko) | 2019-09-04 | 2021-03-12 | 주식회사 레고켐 바이오사이언스 | 인간 ror1에 대한 항체를 포함하는 항체 약물 접합체 및 이의 용도 |
-
2016
- 2016-11-23 AU AU2016359230A patent/AU2016359230B2/en active Active
- 2016-11-23 JP JP2017562979A patent/JP6949732B2/ja active Active
- 2016-11-23 US US15/779,446 patent/US11413353B2/en active Active
- 2016-11-23 CN CN202410065862.6A patent/CN118105513A/zh active Pending
- 2016-11-23 LT LTEPPCT/IB2016/001772T patent/LT3380124T/lt unknown
- 2016-11-23 RS RS20240697A patent/RS65660B1/sr unknown
- 2016-11-23 CN CN202311147181.6A patent/CN117244076A/zh active Pending
- 2016-11-23 CA CA3006242A patent/CA3006242A1/en active Pending
- 2016-11-23 CN CN201680030770.8A patent/CN107847606A/zh active Pending
- 2016-11-23 HR HRP20240795TT patent/HRP20240795T1/hr unknown
- 2016-11-23 SI SI201631824T patent/SI3380124T1/sl unknown
- 2016-11-23 ES ES16868091T patent/ES2979090T3/es active Active
- 2016-11-23 KR KR1020187018066A patent/KR102847342B1/ko active Active
- 2016-11-23 SM SM20240223T patent/SMT202400223T1/it unknown
- 2016-11-23 FI FIEP16868091.6T patent/FI3380124T3/fi active
- 2016-11-23 EP EP16868091.6A patent/EP3380124B1/en active Active
- 2016-11-23 PL PL16868091.6T patent/PL3380124T3/pl unknown
- 2016-11-23 HU HUE16868091A patent/HUE067016T2/hu unknown
- 2016-11-23 DK DK16868091.6T patent/DK3380124T3/da active
- 2016-11-23 CN CN202011108071.5A patent/CN112451682A/zh active Pending
- 2016-11-23 PT PT168680916T patent/PT3380124T/pt unknown
- 2016-11-23 WO PCT/IB2016/001772 patent/WO2017089890A1/en not_active Ceased
- 2016-11-25 TW TW105138775A patent/TWI801332B/zh active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019503980A5 (https=) | ||
| JP2019503981A5 (https=) | ||
| JP2019503979A5 (https=) | ||
| HRP20240795T1 (hr) | Konjugati koji se sastoje od samozapaljujućih skupina i postupci povezani s njima | |
| US11975076B2 (en) | Antibody-drug conjugates comprising branched linkers and methods related thereto | |
| KR101921068B1 (ko) | 단백질-활성제 접합체 및 이의 제조 방법 | |
| JP2021523232A5 (https=) | ||
| KR102847348B1 (ko) | 펩타이드 그룹을 포함하는 접합체 및 이와 관련된 제조방법 | |
| JP2021063058A5 (https=) | ||
| US10036010B2 (en) | Recognition tags for TGase-mediated conjugation | |
| JP7256751B2 (ja) | β－ガラクトシドが導入された自己犠牲リンカーを含む化合物 | |
| US20240131178A1 (en) | Antibody-drug conjugate including antibody against human cldn18.2, and use thereof | |
| JP2022522547A5 (https=) | ||
| US20240261425A1 (en) | Conjugate and the preparing method and use thereof | |
| JP2022530482A (ja) | トリス構造を有するリンカーを含むリガンド―薬物複合体 | |
| JP2026510495A (ja) | ヒトｌ１ｃａｍに対する抗体を含む抗体－薬物コンジュゲートおよびその使用 | |
| US20250242043A1 (en) | Antibody-drug conjugate comprising antibody against human trop2 and use thereof | |
| KR102501394B1 (ko) | 트리스 구조를 가지는 링커를 포함하는 리간드-약물 접합체 | |
| RU2021128538A (ru) | Коньюгаты антитело-лекарственное средство, включающие антитело против человеческого dlk1, и их применение | |
| RU2020140202A (ru) | Композиции и способы, относящиеся к конъюгатам лекарственных средств с антителами против cd19 | |
| RU2025127084A (ru) | Конъюгат антитело-лекарственное средство, содержащий антитела против l1cam человека, и его применение | |
| KR20250163875A (ko) | 핵 위치화 폴리펩타이드 및 컨주게이트 및 이의 용도 | |
| NZ778812B2 (en) | Antibody-drug conjugates including antibody against human dlk1, and use thereof | |
| HK1190330A (en) | Protein-active agent conjugates and method for preparing the same |